3American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines [ J ]. Guidelines for the management of rheumatoid arthritis ; 2002 update [ J ]. Arthritis Rheum, 2002, 46(2) :328 -346.
4Krishnan E, Fries JF. Reduction in long - term functional disability in rheumatoid arthritis from 1977 to 1998 : a longitudinal study of 3035 patients[J]. Am J Med, 2003,115(5):371 -376.
5da Silva E, Doran MF, Crowson CS, et al. Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long - term, population - based assessment [ J ]. Arthritis Rheum, 2003,49(2) :216 -220.
6Lard LR, Visser H, Speyer I, et al. Early venus delayed treatment in patients with recent - onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies [J]. Am J Meal,2001,111(6) :446-451.
7Egsmose C, Lurid B, Borg G, et al. Patients with rheumatoid arthritis bene, fit farm early 2nd line therapy: 5 - year followup of a prospective double blind placebo controlled study[ J]. J Rheumatol , 1995,22(12) :2208 - 2213.
二级参考文献10
1Blass S, Union A, Raymackers J, et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum, 2001, 44: 761-771.
2Saraux A, Berthelot JM, Chales G, et al. Value of laboratory tests in early prediction of rheumatoid arthritis. Arthritis Rheum, 2002, 47: 155-165.
3Vencovsky J, Machacek S, Sedova L, et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis, 2003, 62: 427-430.
4Bacman S, Berra A, Sterin-Borda L, et al. Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjogren syndrome. Invest Ophthalmol Vis Sci, 2001, 42: 321-327.
5Tincani A, Balestrieri G, Allegri F, et al. Overview on anticardiolipin ELISA standardization. J Autoimmun, 2000, 15:195-197.
6Ahmadi K, Wilson C, Tiwana H, et al. Antibodies to Klebsiella pneumoniae lipopoly-saccharide in patients with ankylosing spondylitis. Br J Rheumatol, 1998, 37: 1330-1333.
7Chen XW, Zhang Z, Jiang LM, et al. Elevated interleukin-13 in patients with active lupus nephritis. Chinese Medical Journal, 2001, 114: 1022-1025.
8Braun J, Bollow M, Neure L, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum, 1995, 38: 499-505.
9Watson M, Rudd PM, Bland M, et al. Sugar printing rheumatic diseases: a potential method for disease differentiation using immunoglobulin G oligosaccharides. Arthritis Rheum, 1999, 42: 1682-1690.
10Pap G, Eberhardt R, Rocken C, et al. Expression of stromelysin and urokinase type plasminogen activator protein in resection specimens and biopsies at different stages of osteoarthritis of the knee. Pathol Res Pract, 2000, 196: 219-226.
7National Institute for ClinicalExcellence. Guidance on the use of etanercept and infliximab for the treatment of rheumatoid arthritis. London: National Institute for Clinical Excellence (NICE),2002:22.
8Krishnan E, Fries JF. Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998: a longitudinal study of3035 patients[J]. Am J Med, 2003, 115(5): 371-376.
9DaSilvaE,Doran ME CrowsonCS, et al Deelininguseoforthopedie surgery in patients with rheumatoid arthritis? Results of a long--term, population- based assessment [ J ]. Arthritis Rheum, 2003,49( 2 ) : 216-220.
10Forsblad D' Elia H,Larsen A,Waltbrand E,et al.Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis.Ann Rheum Dis,2003,62(7):617-623.
